Cargando…
IgY antibodies in human nutrition for disease prevention
Oral administration of preformed specific antibodies is an attractive approach against infections of the digestive system in humans and animals in times of increasing antibiotic resistances. Previous studies showed a positive effect of egg yolk IgY antibodies on bacterial intoxications in animals an...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617726/ https://www.ncbi.nlm.nih.gov/pubmed/26487372 http://dx.doi.org/10.1186/s12937-015-0067-3 |
_version_ | 1782396833526448128 |
---|---|
author | Müller, Sandra Schubert, Andreas Zajac, Julia Dyck, Terry Oelkrug, Christopher |
author_facet | Müller, Sandra Schubert, Andreas Zajac, Julia Dyck, Terry Oelkrug, Christopher |
author_sort | Müller, Sandra |
collection | PubMed |
description | Oral administration of preformed specific antibodies is an attractive approach against infections of the digestive system in humans and animals in times of increasing antibiotic resistances. Previous studies showed a positive effect of egg yolk IgY antibodies on bacterial intoxications in animals and humans. Immunization of chickens with specific antigens offers the possibility to create various forms of antibodies. Research shows that orally applied IgY’s isolated from egg yolks can passively cure or prevent diseases of the digestive system. The use of these alternative therapeutic drugs provides further advantages: (1) The production of IgY’s is a non-invasive alternative to current methods; (2) The keeping of chickens is inexpensive; (3) The animals are easy to handle; (4) It avoids repetitive bleeding of laboratory animals; (5) It is also very cost effective regarding the high IgY concentration within the egg yolk. Novel targets of these antigen specific antibodies are Helicobacter pylori and also molecules involved in signaling pathways in gastric cancer. Furthermore, also dental caries causing bacteria like Streptococcus mutans or opportunistic Pseudomonas aeruginosa in cystic fibrosis patients are possible targets. Therefore, IgY’s included in food for human consumption may be able to prevent or cure human diseases. |
format | Online Article Text |
id | pubmed-4617726 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46177262015-10-25 IgY antibodies in human nutrition for disease prevention Müller, Sandra Schubert, Andreas Zajac, Julia Dyck, Terry Oelkrug, Christopher Nutr J Review Oral administration of preformed specific antibodies is an attractive approach against infections of the digestive system in humans and animals in times of increasing antibiotic resistances. Previous studies showed a positive effect of egg yolk IgY antibodies on bacterial intoxications in animals and humans. Immunization of chickens with specific antigens offers the possibility to create various forms of antibodies. Research shows that orally applied IgY’s isolated from egg yolks can passively cure or prevent diseases of the digestive system. The use of these alternative therapeutic drugs provides further advantages: (1) The production of IgY’s is a non-invasive alternative to current methods; (2) The keeping of chickens is inexpensive; (3) The animals are easy to handle; (4) It avoids repetitive bleeding of laboratory animals; (5) It is also very cost effective regarding the high IgY concentration within the egg yolk. Novel targets of these antigen specific antibodies are Helicobacter pylori and also molecules involved in signaling pathways in gastric cancer. Furthermore, also dental caries causing bacteria like Streptococcus mutans or opportunistic Pseudomonas aeruginosa in cystic fibrosis patients are possible targets. Therefore, IgY’s included in food for human consumption may be able to prevent or cure human diseases. BioMed Central 2015-10-20 /pmc/articles/PMC4617726/ /pubmed/26487372 http://dx.doi.org/10.1186/s12937-015-0067-3 Text en © Müller et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Müller, Sandra Schubert, Andreas Zajac, Julia Dyck, Terry Oelkrug, Christopher IgY antibodies in human nutrition for disease prevention |
title | IgY antibodies in human nutrition for disease prevention |
title_full | IgY antibodies in human nutrition for disease prevention |
title_fullStr | IgY antibodies in human nutrition for disease prevention |
title_full_unstemmed | IgY antibodies in human nutrition for disease prevention |
title_short | IgY antibodies in human nutrition for disease prevention |
title_sort | igy antibodies in human nutrition for disease prevention |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617726/ https://www.ncbi.nlm.nih.gov/pubmed/26487372 http://dx.doi.org/10.1186/s12937-015-0067-3 |
work_keys_str_mv | AT mullersandra igyantibodiesinhumannutritionfordiseaseprevention AT schubertandreas igyantibodiesinhumannutritionfordiseaseprevention AT zajacjulia igyantibodiesinhumannutritionfordiseaseprevention AT dyckterry igyantibodiesinhumannutritionfordiseaseprevention AT oelkrugchristopher igyantibodiesinhumannutritionfordiseaseprevention |